Certain Shares of Medivir AB (publ) are subject to a Lock-Up Agreement Ending on 21-MAR-2024. These Shares will be under lockup for 91 days starting from 21-DEC-2023 to 21-MAR-2024.

Details:
Prior to the announcement of the Rights Issue, members of the Board of Director's and shareholding members of Senior Management of the Company have entered into lock-up undertakings, which, among other things and with customary exceptions, mean that they have undertaken not to sell shares in the Company. The lock-up undertakings expire on the day that falls 180 days after the announcement date of the outcome in the Rights Issue.

Furthermore, the Company has undertaken towards Pareto Securities AB and Zonda Partners AB, subject to customary exceptions, not to issue additional shares or other share-related instruments for a period of 90 days after the end of the subscription period.